Онкопедиатрия. 2018; 5: 248-256
Хондробластома: этиология, патогенез, методы диагностики и лечения
https://doi.org/10.15690/onco.v5i4.1968Аннотация
В статье дана характеристика опухоли из клеток хрящевой ткани — хондробластомы. Анализируются современные сведения об этиологии, ключевых звеньях патогенеза, видах опухоли, общих клинических проявлениях, подходах к диагностике и лечению у детей.
Список литературы
1. Xu H, Nugent D, Monforte HL, et al. Chondroblastoma of bone in the extremities: a multicenter retrospective study. J Bone Joint Surg Am. 2015;97(11):925–931. doi: 10.2106/JBJS.N.00992.
2. Chen W, DiFrancesco LM. Chondroblastoma: an update. Arch Pathol Lab Med. 2017;141(6):867– 871. doi: 10.5858/arpa.2016-0281-RS.
3. Konishi E, Nakashima Y, Mano M, et al. Chondroblastoma of extra-craniofacial bones: clinicopathological analyses of 103 cases. Pathol Int. 2017;67(10):495–502. doi: 10.1111/pin.12586.
4. Prashant N, Amber H, Azuhairy A, et al. Spontaneous conventional osteosarcoma transformation of a chondroblastoma first ever case report and literature review. J Orthop Oncol. 2017;3:120. doi: 10.4172/2472-016X.1000120.
5. Punit A, Nadkarni S, Doomra T. Chondroblastoma of diaphysis of radius in a seven year old child. J Orthop Case Rep. 2014;4(3): 32–35. doi: 10.13107/jocr.2250-0685.191.
6. Esmaeili H, Amidfar H, Yavarikia M, Amidfar A. Chondroblastoma of diaphysis of tibia; case report. Am J Med Case Rep. 2016;4(6):215–217.
7. Codman EA. The classic: epiphyseal chondromatous giant cell tumors of the upper end of the humerus. Surg Gynecol Obstet.1931;52:543. Clin Orthop Relat Res. 2006;450:12–16. doi: 10.1097/01.blo.0000229309.90265.
8. Заспа О.А. Гигантская хондробластома бедренной кости // Архив патологии. — 2014. — Т.76. — №6 — С. 61–63. doi: 10.17116/patol201476661-63.
9. Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumours of soft tissue and bone. Lyon: WHO, IARC Press; 2013. 468 p.
10. Миронов С.П., Снетков А.И., Батраков С.Ю., и др. Диагностика и лечение доброкачественных опухолей и опухолеподобных заболеваний костей у детей / Под ред. акад. РАН С.П. Миронова. — М.: ГЭОТАР-Медиа; 2017. — 352 с.
11. Зацепин С.Т. Костная патология взрослых. Руководство для врачей. — М.: Медицина; 2001. — С. 297–312.
12. Sailhan F, Chotel F, Parot R; SOFOP. Chondroblastoma of bone in a pediatric population. J Bone Joint Surg Am. 2009;91(9):2159–2168. doi: 10.2106/JBJS.H.00657.
13. Онкология: учебник с компакт-диском / Под ред. В.И. Чиссова, С.Л. Дарьяловой. — М.: ГЭОТАРМедиа; 2007. — 560 с.
14. Травкина Ю.В., Жевак Т.Н., Литвицкий П.Ф. Хордома: этиология, патогенез, методы диагностики и лечения // Вопросы современной педиатрии. — 2018. — Т.17. — №4 — С. 266–271. doi: 10.15690/vsp.v17i4.1917.
15. Carlson AP, Yonas H, Olson GT, et al. Temporal chondroblastoma with a novel chromosomal translocation (2;5) (q33;q13). Skull Base Rep. 2011;1(1):65–70. doi: 10.1055/s-0031-1275638.
16. Sjögren H, Orndal C, Tingby O, et al. Cytogenetic and spectral karyotype of benign and malignant carriage tumours. Int J Oncol. 2004;24(6):1385–1391.
17. Romeo S, Szuhai K, Nishimori I, et al. A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes. BMC Cancer. 2009;9:393. doi: 10.1186/1471-2407-9-393.
18. Swarts SJ, Neff JR, Johansson SL, et al. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res. 1998;349:189–193. doi.org/10.1097/00003086-199804000-00023.
19. Копнин Б.П., Копнин П.Б., Хромова Н.В., Агапова Л.С. Многоликий р53: разнообразие форм, функций, опухоль супрессирующих и онкогенных активностей // Клиническая онкогематология. — 2008. — Т.1. — №1 — С. 2–9.
20. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol. 2007;8(4):275–283. doi: 10.1038/nrm2147.
21. Strano S, Dell’Orso S, Di Agostino S, et al. Mutant p53: an oncogenic transcription factor. Oncogene. 2007;26(15):2212–2219. doi: 10.1038/sj.onc.1210296.
22. Papachristou DJ, Goodman MA, Cieply K, et al. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis. Hum Pathol. 2006;37(7):890–898. doi: 10.1016/j.humpath.2006.02.014.
23. Ostrowski ML, Johnson ME, Truong LD, et al. Malignant chondroblastoma presenting as a recurrent pelvic tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy. Skeletal Radiol. 1999;28(11):644–650.
24. Григоровский В.В. Гигантоклеточная опухоль кости: морфогенез, клинико-морфологические особенности, дифференциальная диагностика, подходы к лечению // Онкология. — 2014. — Т.14. — №1 — C. 64–76.
25. Демидова И.А. Эпигенетические нарушения при острых лейкозах // Клиническая онкогематология. — 2008. — Т.1. — №1 — С. 16–20.
26. Laird PW. Cancer epigenetic. Hum Mol Genet. 2005;14(Suppl 1):65–76. doi: 10.1093/hmg/ddi113.
27. Fang D, Gan H, Lee JH, et al. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science. 2016;352(6291):1344–1348. doi: 10.1126/science.aae0065.
28. Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45(12):1479–1482. doi: 10.1038/ng.2814.
29. Amary MF, Berisha F, Mozela R, et al. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma. Histopathology. 2016;69(1):121–127. doi: 10.1111/his.12945.
30. Cleven AH, Höcker S, Briaire-de Bruijn I, et al. Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol. 2015;39(11):1576–1583. doi: 10.1097/PAS.0000000000000512.
31. Presneau N, Baumhoer D, Behjati S, et al. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res. 2015;1(2):113–123. doi: 10.1002/cjp2.13.
32. Romeo S, Bovée JV, Jadnanansing NA, et al. Expression of cartilage growth plate signalling molecules in chondroblastoma. J Pathol. 2004;202(1):113–120. doi: 10.1002/path.1501.
33. De Mattos CB, Angsanuntsukh C, Arkader A, Dormans JP. Chondroblastoma and chondromyxoid fibroma. J Am Acad Orthop Surg. 2013;21(4):225–233. doi: 10.5435/JAAOS-21-04-225.
34. Моргун В.А., Семенова Л.А. Хондробластома — диагностика и хирургическое лечение // Кремлевская медицина. Клинический вестник. — 2007. — №1 — С. 52–54.
35. Семенова Л.А., Зубков Д.Е. Клиникоморфологические особенности хондробластомы // Российский педиатрический журнал. — 2011. — №2 — С. 59–61.
36. Farfalli GL, Slullitel PA, Muscolo DL, et al. What happens to the articular surface after curettage for epiphyseal chondroblastoma? A report on functional results, arthritis, and arthroplasty. Clin Orthop Relat Res. 2017;475(3):760–766. doi: 10.1007/s11999-016-4715-5.
37. Erickson JK, Rosenthal DI, Zaleske DJ, et al. Primary treatment of chondroblastoma with percutaneous radio-frequency heat ablation: report of three cases. Radiology. 2001;221(2):463–468. doi: 10.1148/radiol.2212010262.
38. Xie C, Jeys L, James SL. Radiofrequency ablation of chondroblastoma: long-term clinical and imaging outcomes. Eur Radiol. 2015;25(4):1127–1134. doi: 10.1007/s00330-014-3506-1.
39. Lin PP, Thenappan A, Deavers MT, et al. Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005;438:103–109. doi: 10.1097/01.blo.0000179591.72844.c3.
Oncopediatrics. 2018; 5: 248-256
Chondroblastoma: Etiology, Pathogenesis, Methods of Diagnosis and Treatment
https://doi.org/10.15690/onco.v5i4.1968Abstract
The article provides the characteristic of a tumor from cells of cartilaginous tissue — chondroblastoma. Current data on etiology, key links of pathogenesis, types of tumor, General clinical manifestations, approaches to diagnosis and treatment in children are analyzed.
References
1. Xu H, Nugent D, Monforte HL, et al. Chondroblastoma of bone in the extremities: a multicenter retrospective study. J Bone Joint Surg Am. 2015;97(11):925–931. doi: 10.2106/JBJS.N.00992.
2. Chen W, DiFrancesco LM. Chondroblastoma: an update. Arch Pathol Lab Med. 2017;141(6):867– 871. doi: 10.5858/arpa.2016-0281-RS.
3. Konishi E, Nakashima Y, Mano M, et al. Chondroblastoma of extra-craniofacial bones: clinicopathological analyses of 103 cases. Pathol Int. 2017;67(10):495–502. doi: 10.1111/pin.12586.
4. Prashant N, Amber H, Azuhairy A, et al. Spontaneous conventional osteosarcoma transformation of a chondroblastoma first ever case report and literature review. J Orthop Oncol. 2017;3:120. doi: 10.4172/2472-016X.1000120.
5. Punit A, Nadkarni S, Doomra T. Chondroblastoma of diaphysis of radius in a seven year old child. J Orthop Case Rep. 2014;4(3): 32–35. doi: 10.13107/jocr.2250-0685.191.
6. Esmaeili H, Amidfar H, Yavarikia M, Amidfar A. Chondroblastoma of diaphysis of tibia; case report. Am J Med Case Rep. 2016;4(6):215–217.
7. Codman EA. The classic: epiphyseal chondromatous giant cell tumors of the upper end of the humerus. Surg Gynecol Obstet.1931;52:543. Clin Orthop Relat Res. 2006;450:12–16. doi: 10.1097/01.blo.0000229309.90265.
8. Zaspa O.A. Gigantskaya khondroblastoma bedrennoi kosti // Arkhiv patologii. — 2014. — T.76. — №6 — S. 61–63. doi: 10.17116/patol201476661-63.
9. Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumours of soft tissue and bone. Lyon: WHO, IARC Press; 2013. 468 p.
10. Mironov S.P., Snetkov A.I., Batrakov S.Yu., i dr. Diagnostika i lechenie dobrokachestvennykh opukholei i opukholepodobnykh zabolevanii kostei u detei / Pod red. akad. RAN S.P. Mironova. — M.: GEOTAR-Media; 2017. — 352 s.
11. Zatsepin S.T. Kostnaya patologiya vzroslykh. Rukovodstvo dlya vrachei. — M.: Meditsina; 2001. — S. 297–312.
12. Sailhan F, Chotel F, Parot R; SOFOP. Chondroblastoma of bone in a pediatric population. J Bone Joint Surg Am. 2009;91(9):2159–2168. doi: 10.2106/JBJS.H.00657.
13. Onkologiya: uchebnik s kompakt-diskom / Pod red. V.I. Chissova, S.L. Dar'yalovoi. — M.: GEOTARMedia; 2007. — 560 s.
14. Travkina Yu.V., Zhevak T.N., Litvitskii P.F. Khordoma: etiologiya, patogenez, metody diagnostiki i lecheniya // Voprosy sovremennoi pediatrii. — 2018. — T.17. — №4 — S. 266–271. doi: 10.15690/vsp.v17i4.1917.
15. Carlson AP, Yonas H, Olson GT, et al. Temporal chondroblastoma with a novel chromosomal translocation (2;5) (q33;q13). Skull Base Rep. 2011;1(1):65–70. doi: 10.1055/s-0031-1275638.
16. Sjögren H, Orndal C, Tingby O, et al. Cytogenetic and spectral karyotype of benign and malignant carriage tumours. Int J Oncol. 2004;24(6):1385–1391.
17. Romeo S, Szuhai K, Nishimori I, et al. A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes. BMC Cancer. 2009;9:393. doi: 10.1186/1471-2407-9-393.
18. Swarts SJ, Neff JR, Johansson SL, et al. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res. 1998;349:189–193. doi.org/10.1097/00003086-199804000-00023.
19. Kopnin B.P., Kopnin P.B., Khromova N.V., Agapova L.S. Mnogolikii r53: raznoobrazie form, funktsii, opukhol' supressiruyushchikh i onkogennykh aktivnostei // Klinicheskaya onkogematologiya. — 2008. — T.1. — №1 — S. 2–9.
20. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol. 2007;8(4):275–283. doi: 10.1038/nrm2147.
21. Strano S, Dell’Orso S, Di Agostino S, et al. Mutant p53: an oncogenic transcription factor. Oncogene. 2007;26(15):2212–2219. doi: 10.1038/sj.onc.1210296.
22. Papachristou DJ, Goodman MA, Cieply K, et al. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis. Hum Pathol. 2006;37(7):890–898. doi: 10.1016/j.humpath.2006.02.014.
23. Ostrowski ML, Johnson ME, Truong LD, et al. Malignant chondroblastoma presenting as a recurrent pelvic tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy. Skeletal Radiol. 1999;28(11):644–650.
24. Grigorovskii V.V. Gigantokletochnaya opukhol' kosti: morfogenez, kliniko-morfologicheskie osobennosti, differentsial'naya diagnostika, podkhody k lecheniyu // Onkologiya. — 2014. — T.14. — №1 — C. 64–76.
25. Demidova I.A. Epigeneticheskie narusheniya pri ostrykh leikozakh // Klinicheskaya onkogematologiya. — 2008. — T.1. — №1 — S. 16–20.
26. Laird PW. Cancer epigenetic. Hum Mol Genet. 2005;14(Suppl 1):65–76. doi: 10.1093/hmg/ddi113.
27. Fang D, Gan H, Lee JH, et al. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas. Science. 2016;352(6291):1344–1348. doi: 10.1126/science.aae0065.
28. Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45(12):1479–1482. doi: 10.1038/ng.2814.
29. Amary MF, Berisha F, Mozela R, et al. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma. Histopathology. 2016;69(1):121–127. doi: 10.1111/his.12945.
30. Cleven AH, Höcker S, Briaire-de Bruijn I, et al. Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol. 2015;39(11):1576–1583. doi: 10.1097/PAS.0000000000000512.
31. Presneau N, Baumhoer D, Behjati S, et al. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res. 2015;1(2):113–123. doi: 10.1002/cjp2.13.
32. Romeo S, Bovée JV, Jadnanansing NA, et al. Expression of cartilage growth plate signalling molecules in chondroblastoma. J Pathol. 2004;202(1):113–120. doi: 10.1002/path.1501.
33. De Mattos CB, Angsanuntsukh C, Arkader A, Dormans JP. Chondroblastoma and chondromyxoid fibroma. J Am Acad Orthop Surg. 2013;21(4):225–233. doi: 10.5435/JAAOS-21-04-225.
34. Morgun V.A., Semenova L.A. Khondroblastoma — diagnostika i khirurgicheskoe lechenie // Kremlevskaya meditsina. Klinicheskii vestnik. — 2007. — №1 — S. 52–54.
35. Semenova L.A., Zubkov D.E. Klinikomorfologicheskie osobennosti khondroblastomy // Rossiiskii pediatricheskii zhurnal. — 2011. — №2 — S. 59–61.
36. Farfalli GL, Slullitel PA, Muscolo DL, et al. What happens to the articular surface after curettage for epiphyseal chondroblastoma? A report on functional results, arthritis, and arthroplasty. Clin Orthop Relat Res. 2017;475(3):760–766. doi: 10.1007/s11999-016-4715-5.
37. Erickson JK, Rosenthal DI, Zaleske DJ, et al. Primary treatment of chondroblastoma with percutaneous radio-frequency heat ablation: report of three cases. Radiology. 2001;221(2):463–468. doi: 10.1148/radiol.2212010262.
38. Xie C, Jeys L, James SL. Radiofrequency ablation of chondroblastoma: long-term clinical and imaging outcomes. Eur Radiol. 2015;25(4):1127–1134. doi: 10.1007/s00330-014-3506-1.
39. Lin PP, Thenappan A, Deavers MT, et al. Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005;438:103–109. doi: 10.1097/01.blo.0000179591.72844.c3.
